SFO
ELV icon

Stenger Family Office’s Elevance Health ELV Stock Holding History

Stenger Family Office’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$568K Buy
+1,539
New +$644K 0.19% 69

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Stenger Family Office's ELV Position: Q4 2024 in Review

Stenger Family Office opened a new position in Elevance Health (ELV) in Q4 2024: 1,539 shares worth $568K. The stake represents 0.19% of the portfolio and ranks #69 among its holdings.

1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Stenger Family Office held 1,539 shares of Elevance Health worth $568K as of Q4 2024.
  • Elevance Health was a new Stenger Family Office position in Q4 2024.
  • Elevance Health made up 0.19% of Stenger Family Office's portfolio in Q4 2024, its #69 holding.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Stenger Family Office's 13F filing for Q4 2024, filed 13 Feb 2025.